August 02, 2024 at 02:58PM FDA Approves First Gene Therapy to Treat Adults with Metastatic Synovial Sarcoma

FDA approves Tecelra, a gene therapy to treat adults with unresectable or metastatic synovial sarcoma. Tecelra is also the first FDA-approved T cell receptor (TCR) gene therapy.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/KaLZtlR